A carregar...

Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in man.

1. Epoprostenol (prostacyclin, PGI2) has been evaluated in clinical trials in peripheral vascular disease and other conditions chiefly on the basis of its platelet inhibitory properties. These therapeutic evaluations have proceeded in the absence of evidence as to the optimum infusion regimen for ep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sinzinger, H, Fitscha, P, Kaliman, J, Silberbauer, K, O'Grady, J
Formato: Artigo
Idioma:Inglês
Publicado em: 1987
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1386332/
https://ncbi.nlm.nih.gov/pubmed/3325091
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!